Xhale, Inc.

02/13/2018

For new and current users of the Alar sensor, please view the Nasal Alar Sp02 sensor's in-service video. The sensor is a great solution for optimal Sp02 monitoring!

Nasal Alar Sp02 sensor in-service. A user guide to support proper application, positioning, site check/rotate, and optimal performance tips. For more informa...

02/13/2018

The Nasal Alar sensor is rapidly becoming the go to solution for optimal Sp02 monitoring! We have just added our new product video to the XA Youtube channel for interested customers to learn about the sensor's clinical and economic benefits!

The Nasal Alar Sp02 sensor is a great solution to provide accurate and reliable monitoring in critical situations when readings are needed most. For ordering...

08/16/2017

The Alar sensor is now FDA approved for use to “> 15kg and 4 years old or older”. This will be a great opportunity to provide more accurate and reliable Sp02 monitoring in our pediatric patient population!

01/24/2017

Today at the SCCM conference, Barnes Jewish researchers are presenting the results of their study comparing the Alar sensor to the forehead sensor. The results show that the Alar sensor is more reliable, more accurate and less prone to skin breakdown.

12/23/2016

09/04/2015

Press Release issued Sep 4, 2015: Xhale Assurance, Inc. today announced it has received CE Mark approval of its Nasal Alar SpO2 Sensor for clinical use in CE countries. A CE Mark verifies the Assurance® Nasal Alar SpO2™ Sensor has met all applicable directives of the European Commission (EC) and sub…

07/30/2015

The A1x Nasal Alar Sp02 sensor can offer great advantages for patients and providers!

05/01/2015

If you are attending NTI this month in San Diego, please stop by and see us at booth 3028! The A1x Nasal Alar Sp02 sensor is now available and we look forward to discussing how it can be the solution for low perfusion patients!

03/26/2015

Xhale Assurance Announces FDA Approval of its Second Generation Nasal Alar Sp02 Sensor

Xhale Assurance, Inc., developer of the patented Assurance® Nasal AlarSpO2TM Sensor, today announced FDA clearance and the global launch of its second-generation pulse oximetry sensor. The new Assurance® Nasal AlarSpO2TM Sensor is now compatible with the majority of pulse oximetry monitors in use in…

03/23/2015

GAINESVILLE, FL March 18, 2015 - Xhale Assurance, Inc. Xhale Assurance, Inc., developer of the patented Assurance® Nasal AlarSpO2TMSensor, today announced FD…